Tandem Diabetes Care, Inc. (TNDM)

20,59 -0,65 (-3,06%) Börsenschluss: 04:00PM EDT

Tandem Diabetes Care, Inc.

11075 Roselle Street
San Diego, CA 92121
United States
858 366 6900
https://www.tandemdiabetes.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 2.600

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. John F. Sheridan	Pres, CEO & Director	1,23M	N/A	1955
Ms. Leigh A. Vosseller	Exec. VP, CFO & Treasurer	665,43k	N/A	1973
Mr. David B. Berger Esq.	Exec. VP & COO	670,18k	1,73M	1970
Ms. Susan M. Morrison	Exec. VP & Chief Admin. Officer	674,76k	N/A	1979
Mr. Brian B. Hansen	Exec. VP & Chief Commercial Officer	650,19k	N/A	1968
Ms. Elizabeth Anne Gasser	Exec. VP & Chief Strategy Officer	606,83k	N/A	1977
Mr. Rick A. Carpenter	Chief Technical Officer	N/A	N/A	1963
Ms. Shannon M. Hansen	Chief Legal, Privacy & Compliance Officer and Sec.	N/A	N/A	1966
Mr. Ross Sylvia	VP of Marketing	N/A	N/A	N/A
Mr. Tom Fox	Chief HR Officer	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Corporate Governance

Tandem Diabetes Care, Inc.s ISS Governance QualityScore, Stand 1. September 2023, lautet 3. Die grundlegenden Scores sind Audit: 3, Vorstand: 1, Shareholderrechte: 4, Kompensation: 5.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.